Drug treatment therapy

DLH to Provide Information Technology Services at National Institute on Drug Abuse

DLH announced that it has been awarded a contract to continue providing information technology services for the National Institutes of Health’s (“NIH”) National Institute on Drug Abuse (“NIDA”).

DLH Reports Fiscal 2024 First Quarter Results

DLH today announced financial results for its fiscal first quarter ended December 31, 2023.

DLH to Participate in Alliance Global Partners’ Virtual Technology Conference

DLH today announced that it will participate in the Alliance Global Partners’ Virtual Technology Conference on February 7, 2024.

Industry-Recognized Technology Leader Joins DLH as Strategic Advisor

DLH today announced that Cora Carmody has been appointed to a strategic advisory role for the Company.

Leading Federal Health IT Executive Appointed to Strategic Advisory Role at DLH

DLH today announced that David Affeldt has been appointed to a strategic advisory role for the Company, providing insight to executive management and the Board of Directors on a broad range of information technology solutions.

DLH to Participate in Upcoming Sidoti Micro Cap Conference

DLH announced that it will participate in the Sidoti & Company LLC (“Sidoti”) Virtual Micro Cap Conference on August 16, 2023.

DLH Reports Fiscal 2023 Third Quarter Results

DLH today announced financial results for its fiscal third quarter ended June 30, 2023.

DLH to Expand Digital Transformation Services at the National Heart, Lung, and Blood Institute

DLH today announced that it has been awarded a contract to provide agile development, data sciences, and health IT services for NIH.

DLH to Announce Fiscal 2023 Third Quarter Financial Results

DLH will release financial results for its fiscal third quarter ended June 30, 2023 on August 2, 2023 after the market closes.